Michael K Wong

6PUBLICATIONS
103CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2025
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma.

Elizabeth M Burton, Denái R Milton, Michael T Tetzlaff

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|May 30, 2025
New Standards in the Treatment of Advanced Metastatic Melanoma: Immunotherapy and BRAF-Targeted Therapies as Emerging Paradigms.

Firas Kreidieh, Michael K Wong

|Oct 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.

Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder

|Jun 07, 2023
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.

Hannah Y Chen, Weilu Zhao, Shorook Na'ara

|Dec 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.

Christine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan

Pageof 1

Frequent Collaborators

3 joint publications

Hussein A Tawbi

3 joint publications

Michael Davies

2 joint publications

Padmanee Sharma

2 joint publications

Jennifer L McQuade